Bishopsgate advises Neoceuticals on its sale to Guangxi Minglei Weisheng Pharmaceutical Co

Back

Location

Sector

Healthcare

Deal Type

Sale

Value

Bishopsgate Corporate Finance advised the founders of Neoceuticals Limited, a paediatric and specialist nutritional product provider for the healthcare market on its sale to Guangxi Minglei Weisheng Pharmaceutical Co., Ltd., a Chinese pharmaceutical company.

Bishopsgate worked with the shareholders at Neoceuticals to map out an international buyer audience due to their products applicability in Asian markets.

Guangxi Minglei Weisheng Pharmaceutical Co., Ltd., a Chinese pharmaceutical company acquired the company with an ambition to strengthen new drug research and development, and expand its global business.